Correction: The effect of dapagliflozin on cardiorespiratory fitness in patients with coronary heart disease and type 2 diabetes mellitus following PCI: a single-center prospective randomized controlled study - Top-Institutions - MDSpire

Correction: The effect of dapagliflozin on cardiorespiratory fitness in patients with coronary heart disease and type 2 diabetes mellitus following PCI: a single-center prospective randomized controlled study

  • By

  • Jiali Yang

  • Xinru Li

  • Liangqiu Tang

  • Wenmao Fan

  • Aihua Li

  • Wanming Zhou

  • Jungang Pang

  • Qiuxiao Yuan

  • Ming Zhong

  • Jinhui Hou

  • Lan Wang

  • Wenjiao Liao

  • Xiangyang Liu

  • BMC Cardiovascular

  • June 2, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Brigham and Women's Hospital
    Brigham and Women's Hospital

    Boston, Massachusetts

    Key Differentiators

    • Cardiology
    • Diabetes

  • #2

    Duke University Hospital
    Duke University Hospital

    Durham, North Carolina

    Key Differentiators

    • Cardiology
    • Clinical Research

Original Source(s)

Correction: The effect of dapagliflozin on cardiorespiratory fitness in patients with coronary heart disease and type 2 diabetes mellitus following PCI: a single-center prospective randomized controlled study

  • by Jiali Yang, Xinru Li, Liangqiu Tang, Wenmao Fan, Aihua Li, Wanming Zhou, Jungang Pang, Qiuxiao Yuan, Ming Zhong, Jinhui Hou, Lan Wang, Wenjiao Liao, Xiangyang Liu, BMC Cardiovascular

  • June 2, 2026

Related Content

A review of the pathogenic mechanism and clinical management progress of in-stent calcification restenosis

Association of achieved LDL-C levels with global coagulability and clinical outcomes in patients with acute coronary syndrome receiving PCSK9 inhibitors: a prospective cohort study

Association of DAPT duration with bleeding and ischemic outcomes after percutaneous coronary intervention with drug-coated balloons: a meta-analysis